Axsome Therapeutics, Inc. · NASDAQ:AXSM
Jacobson Mark L. sold 4,750 Axsome Therapeutics, Inc. shares (Form 4)
Traded May 4 to May 5, 2026 · Filed May 5, 2026
From May 4 to May 5, 2026, Jacobson Mark L. (Chief Operating Officer) sold 4,750 Axsome Therapeutics, Inc. shares at an average US$227.95 for US$1.08M under a trading plan, leaving 0 shares. Filed May 5, 2026 (Form 4).
- Sold
- 4,750 shares
- Price
- US$227.95 average (US$227.94 to US$228.18)
- Value
- US$1.08M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | Option exercise | 4,517 | US$12.95 | 4,517 | Direct |
| May 4, 2026 | Common Stock | Sale | 4,517 | US$227.94 | 0 | Direct |
| May 5, 2026 | Common Stock | Option exercise | 233 | US$12.95 | 233 | Direct |
| May 5, 2026 | Common Stock | Sale | 233 | US$228.18 | 0 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Jacobson Mark L.
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Jacobson Mark L. · Sep 3, 2026
- Form 4 · Tabuteau Herriot · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Jeffs Roger · Jun 11, 2026
- Form 4 · Mahony Susan · Jun 10, 2026